Overview
rs6759892 is a genetic variant.
This variant is located on chromosome 2. The variations at position 233693023 are the genetic letters G/G, T/T, G/T
Since humans have each twice (one from each parent), these letter-variations occur on both chromosomes. People can have the same or different letters on both chromosomes. Every person's individual variation combination is referred to as genotype. For variant rs6759892 there are 3 currently known genotypes : G/G, T/T or G/T
Short Overview
Variant Location
rs6759892 is located on gene in chromsome 2. Use the genome browser to explore the location of rs6759892 and its genetic neighbourhood.
Conditions & Traits
rs6759892 affects the following conditions and traits:
There are currently 0 conditions and 0 traits associated with rs6759892.
Pathogenicity
rs6759892 affects the following conditions:
There are currently 0 conditions associated with rs6759892.
Genome Browser
This interactive browser visualizes what no human can see with the naked eye - our DNA. From a down to a specific position on a . The position you are looking at here is the exact location of variant rs. Explore more variants and their effects on the body by browsing left and right along the DNA strand.
Did you know genetic variants affect drugs?
Mutations are changes in genes and genetic variations are differences in the DNA among people. Variants are tiny changes in just one piece of the DNA while haplotypes are groups of these changes that usually come together.
Conditions & Traits of rs6759892
Current research shows 0 conditions and 0 traits.
Conditions
0Pharmacogenetics
The genetic variant rs6759892 impacts how certain medications work in the body. This difference may cause some of us to require different dosage amounts to achieve the desired effects, while others might experience more apparent side-effects. As a result, healthcare providers may need to adjust prescriptions for those individuals with rs6759892. Ultimately, understanding our genetic makeup helps improve the overall effectiveness and usability of medications. Tailoring treatments based on genetics ensures a safer, more personalized healthcare experience.
Genotype
Level of evidence
Impacts
Summary
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have increased Side Effects to DEFERIPRONE.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/T have decreased Side Effects to DEFERIPRONE.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype T/T have decreased Drug Effect to DEFERIPRONE.
more info
Legend:
Increased
Decreased
No known effect
Genotype
Level of evidence
Impacts
Summary
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have increased Dosage to VALPROIC ACID.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/T have increased Dosage to VALPROIC ACID.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype T/T have decreased Dosage to VALPROIC ACID.
more info
Legend:
Increased
Decreased
No known effect
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype G/G have increased Side Effects to DEFERIPRONE.
Level of evidence
More info
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype G/T have decreased Side Effects to DEFERIPRONE.
Level of evidence
More info
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype T/T have decreased Drug Effect to DEFERIPRONE.
Level of evidence
More info
Legend:
Increased
Decreased
No known effect
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype G/G have increased Dosage to VALPROIC ACID.
Level of evidence
More info
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype G/T have increased Dosage to VALPROIC ACID.
Level of evidence
More info
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype T/T have decreased Dosage to VALPROIC ACID.
Level of evidence
More info
Legend:
Increased
Decreased
No known effect
Drugs related to rs6759892
All drugs that are linked to rs6759892 are listed here.
Studies and Sources
All of the resources below examine variant rs6759892
Binliang Liu, Tao An, Meiying Li, Zongbi Yi, Chunxiao Li, Xiaoying Sun, Xiuwen Guan, Lixi Li, Yanfeng Wang, Yuhui Zhang, Binghe Xu, Fei Ma, Yixin Zeng
Víctor M. Salinas-Torres, Hugo L. Gallardo-Blanco, Rafael A. Salinas-Torres, Ricardo M. Cerda-Flores, José J. Lugo-Trampe, Daniel Z. Villarreal-Martínez, Laura E. Martínez de Villarreal
Donatella Pastore, Francesca Pacifici, Kunjan R. Dave, Raffaele Palmirotta, Alfonso Bellia, Guido Pasquantonio, Fiorella Guadagni, Giulia Donadel, Nicola Di Daniele, Pasquale Abete, Davide Lauro, Tatjana Rundek, Miguel A. Perez-Pinzon, David Della-Morte